Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP301059.RAW0HFnOiny0JeLG9hmESMWDhwT7THUz-G76bDdzKVEi4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP301059.RAW0HFnOiny0JeLG9hmESMWDhwT7THUz-G76bDdzKVEi4130_assertion type Assertion NP301059.RAW0HFnOiny0JeLG9hmESMWDhwT7THUz-G76bDdzKVEi4130_head.
- NP301059.RAW0HFnOiny0JeLG9hmESMWDhwT7THUz-G76bDdzKVEi4130_assertion description "[Finally, our findings highlight that pharmacological inhibition of Cdk2 activity is a potential therapeutical principle for cancer therapy, in particular for tumors with activated Myc or Ras.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP301059.RAW0HFnOiny0JeLG9hmESMWDhwT7THUz-G76bDdzKVEi4130_provenance.
- NP301059.RAW0HFnOiny0JeLG9hmESMWDhwT7THUz-G76bDdzKVEi4130_assertion evidence source_evidence_literature NP301059.RAW0HFnOiny0JeLG9hmESMWDhwT7THUz-G76bDdzKVEi4130_provenance.
- NP301059.RAW0HFnOiny0JeLG9hmESMWDhwT7THUz-G76bDdzKVEi4130_assertion SIO_000772 19966300 NP301059.RAW0HFnOiny0JeLG9hmESMWDhwT7THUz-G76bDdzKVEi4130_provenance.
- NP301059.RAW0HFnOiny0JeLG9hmESMWDhwT7THUz-G76bDdzKVEi4130_assertion wasDerivedFrom befree-20150227 NP301059.RAW0HFnOiny0JeLG9hmESMWDhwT7THUz-G76bDdzKVEi4130_provenance.
- NP301059.RAW0HFnOiny0JeLG9hmESMWDhwT7THUz-G76bDdzKVEi4130_assertion wasGeneratedBy ECO_0000203 NP301059.RAW0HFnOiny0JeLG9hmESMWDhwT7THUz-G76bDdzKVEi4130_provenance.